Literature DB >> 2618774

Calcium and magnesium concentrations in affective disorder: difference between plasma and serum in relation to symptoms.

J Linder1, K Brismar, J Beck-Friis, J Sääf, L Wetterberg.   

Abstract

Morning (0800) plasma and serum and mean diurnal (24-h) serum calcium (Ca) and magnesium (Mg) concentrations were investigated in 56 depressed patients, 32 with acute major depression, 26 of these restudied in remission, 24 patients with longstanding depression, mainly treated with lithium, and in 27 healthy controls. All subjects were rated with the Comprehensive Psychopathological Rating Scale (CPRS). Significant differences between the groups were found for 0800 and 24-h serum Ca and Mg, 0800 plasma Mg, but not for 0800 plasma Ca. Elevations of serum Ca and Mg, plasma Mg but not plasma Ca were noted in the lithium-treated patients. Sex differences for plasma but not serum levels were seen in remission and in the controls. Depressive symptoms were negatively correlated to 0800 plasma Ca in the acute state and positively to 0800 and 24-h serum Ca and Mg in remission and longstanding depression. This difference between plasma and serum in relation to symptoms could reflect a change in a calcium binding factor present in plasma but not in serum, connected with biological factors of affective disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2618774     DOI: 10.1111/j.1600-0447.1989.tb03021.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  6 in total

1.  Modulation of antidepressant-like activity of magnesium by serotonergic system.

Authors:  E Poleszak
Journal:  J Neural Transm (Vienna)       Date:  2007-04-20       Impact factor: 3.575

2.  Antidepressant-like activity of magnesium in the olfactory bulbectomy model is associated with the AMPA/BDNF pathway.

Authors:  Bartlomiej Pochwat; Magdalena Sowa-Kucma; Katarzyna Kotarska; Paulina Misztak; Gabriel Nowak; Bernadeta Szewczyk
Journal:  Psychopharmacology (Berl)       Date:  2014-07-16       Impact factor: 4.530

3.  Effects of vitamin D and/or magnesium supplementation on mood, serum levels of BDNF, inflammatory biomarkers, and SIRT1 in obese women: a study protocol for a double-blind, randomized, placebo-controlled trial.

Authors:  Behnaz Abiri; Mohammadreza Vafa
Journal:  Trials       Date:  2020-02-26       Impact factor: 2.279

4.  Potential Biomarkers for Predicting Depression in Diabetes Mellitus.

Authors:  Xiuli Song; Qiang Zheng; Rui Zhang; Miye Wang; Wei Deng; Qiang Wang; Wanjun Guo; Tao Li; Xiaohong Ma
Journal:  Front Psychiatry       Date:  2021-11-29       Impact factor: 4.157

5.  Magnesium and mood disorders: systematic review and meta-analysis.

Authors:  Danny Phelan; Patricio Molero; Miguel A Martínez-González; Marc Molendijk
Journal:  BJPsych Open       Date:  2018-07

6.  Effects of Magnesium Supplementation on Unipolar Depression: A Placebo-Controlled Study and Review of the Importance of Dosing and Magnesium Status in the Therapeutic Response.

Authors:  Beata Ryszewska-Pokraśniewicz; Anna Mach; Michał Skalski; Piotr Januszko; Zbigniew M Wawrzyniak; Ewa Poleszak; Gabriel Nowak; Andrzej Pilc; Maria Radziwoń-Zaleska
Journal:  Nutrients       Date:  2018-08-03       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.